Literature DB >> 10049353

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.

W X Zong1, L C Edelstein, C Chen, J Bash, C Gélinas.   

Abstract

Bcl-2-family proteins are key regulators of the apoptotic response. Here, we demonstrate that the pro-survival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB. We show that bfl-1 gene expression is dependent on NF-kappaB activity and that it can substitute for NF-kappaB to suppress TNFalpha-induced apoptosis. bfl-1 promoter analysis identified an NF-kappaB site responsible for its Rel/NF-kappaB-dependent induction. The expression of bfl-1 in immune tissues supports the protective role of NF-kappaB in the immune system. The activation of Bfl-1 may be the means by which NF-kappaB functions in oncogenesis and promotes cell resistance to anti-cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049353      PMCID: PMC316475          DOI: 10.1101/gad.13.4.382

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  37 in total

Review 1.  The Bcl-2 protein family: arbiters of cell survival.

Authors:  J M Adams; S Cory
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

2.  Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect.

Authors:  W X Zong; J Bash; C Gélinas
Journal:  Cell Death Differ       Date:  1998-11       Impact factor: 15.828

3.  Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.

Authors:  Z G Liu; H Hsu; D V Goeddel; M Karin
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.

Authors:  M Wu; H Lee; R E Bellas; S L Schauer; M Arsura; D Katz; M J FitzGerald; T L Rothstein; D H Sherr; G E Sonenshein
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

5.  Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells.

Authors:  A Karsan; E Yee; K Kaushansky; J M Harlan
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

6.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

Authors:  C Y Wang; M W Mayo; R G Korneluk; D V Goeddel; A S Baldwin
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

7.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

8.  An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

Authors:  A A Beg; D Baltimore
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

9.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

10.  A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation.

Authors:  E Y Lin; A Orlofsky; H G Wang; J C Reed; M B Prystowsky
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

View more
  167 in total

1.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

Authors:  H H Lee; H Dadgostar; Q Cheng; J Shu; G Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.

Authors:  C Y Wang; D C Guttridge; M W Mayo; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 3.  Apoptosis and cancer drug targeting.

Authors:  W R Sellers; D E Fisher
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 4.  NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance.

Authors:  V Calabrese; T E Bates; A M Stella
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

5.  Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.

Authors:  Béatrice Rayet; Yongjun Fan; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

6.  NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.

Authors:  S Kreuz; D Siegmund; P Scheurich; H Wajant
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 7.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

8.  v-Src generates a p53-independent apoptotic signal.

Authors:  B L Webb; E Jimenez; G S Martin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

9.  Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Antonia M Joussen; Alexandra Lappas; Bernd Kirchhof; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

10.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.